Literature DB >> 28954353

[Comparisons of efficacy and safety of CBV, BEAM and BEAC high-dose therapy followed by autologous hematopoietic stem cell transplantation in Hodgkin's lymphoma].

Y W Shi, P Liu, S Y Zhou, J L Yang, X H Han, X H He, C G Zhang, L Gui, Y Qin, S Yang, L Y Zhao, J R Yao, S X Zhang, S K Wu, F Pan, Y Sun, Y K Shi1.   

Abstract

Entities:  

Year:  2017        PMID： 28954353     DOI： 10.3760/cma.j.issn.0253-2727.2017.08.013

Source DB:  PubMed          Journal:  Zhonghua Xue Ye Xue Za Zhi        ISSN： 0253-2727


× No keyword cloud information.
  2 in total

1.  Recombinant human thrombopoietin prior to mobilization chemotherapy facilitates platelet recovery in autologous transplantation in patients with lymphoma: Results of a prospective randomized study.

Authors:  Hongnan Mo; Peng Liu; Yan Qin; Xiaohui He; Xiaohong Han; Jiarui Yao; Weicai Su; Shuxiang Zhang; Le Tang; Fengyi Zhao; Lin Gui; Sheng Yang; Jianliang Yang; Shengyu Zhou; Zhishang Zhang; Yuankai Shi
Journal:  Chronic Dis Transl Med       Date:  2021-06-24

2.  Gastrointestinal Bleeding Secondary to High-Dose Melphalan Pretreatment in Patients with Multiple Myeloma Was Associated with the Mode of Melphalan Administration.

Authors:  Qunfang Ge; Yi Wang; Huiling Zhu; Kaihong Xu; Lixia Sheng; Xiaoyan Yan; Guifang Ouyang
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-11       Impact factor: 2.650
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.